Literature DB >> 31272362

Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491.

Yingying Chen1, Yuqiang Zhang1, Wei Song2, Ying Zhang1, Xiu Dong3, Mingqi Tan1.   

Abstract

BACKGROUND: Ginsenoside Rh2 (Rh2), which is extracted from ginseng, exerts antitumor activity. Here we would like to study the role of Rh2 on hypoxia-induced migration in lung adenocarcinoma.
METHODS: Lung adenocarcinoma A549 and H1299 cells were cultured in 1% O2 condition to mimic the hypoxic tumor microenvironment. The migrations of cancer cells were measured by transwell assay and scratch assay.
RESULTS: Rh2 could inhibit hypoxia-induced A549 and H1299 cell migration via increase of mir-491 expression. Further, mir-491 antisense oligonucleotide could repress hypoxia-induced migration and the expression of matrix metalloproteinase (MMP)-9 expression in Rh2-treated A549 cells.
CONCLUSION: These findings suggest that Rh2 exerts anti-metastasis activity in the hypoxic tumor microenvironment in lung adenocarcinoma cells via mir-491. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Ginsenoside Rh2; antitumor activity; hypoxia; lung adenocarcinoma; migration; mir-491.

Year:  2019        PMID: 31272362     DOI: 10.2174/1871520619666190704165205

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  8 in total

1.  Study on the Mechanism of Ginseng in the Treatment of Lung Adenocarcinoma Based on Network Pharmacology.

Authors:  Qiu-Yue Li; Cheng-Zhi Hou; Li-Ping Yang; Xue-Lei Chu; Yuan Wang; Ping Zhang; Yong Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-31       Impact factor: 2.629

2.  Long Non-Coding RNA H19 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Breast Cancer Cells by Targeting miR-491-5p/ZNF703 Axis.

Authors:  Yongkun Wang; Zhen Wu; Yingxue Li; Zheng Zheng; Jinqiang Yan; Shuyan Tian; Lin Han
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

Review 3.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

4.  Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.

Authors:  Jae Eun Park; Hyeon Woo Kim; Sung Hwan Yun; Sun Jung Kim
Journal:  J Ginseng Res       Date:  2021-08-27       Impact factor: 6.060

Review 5.  Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development.

Authors:  Ye Jin; Tianjia Liu; Haoming Luo; Yangyang Liu; Da Liu
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

Review 6.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 7.  Anti-Angiogenic Properties of Ginsenoside Rg3.

Authors:  Maryam Nakhjavani; Eric Smith; Amanda R Townsend; Timothy J Price; Jennifer E Hardingham
Journal:  Molecules       Date:  2020-10-23       Impact factor: 4.411

Review 8.  Anticancer Activities of Ginsenosides, the Main Active Components of Ginseng.

Authors:  Heeok Hong; Delgerzul Baatar; Seong Gu Hwang
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-03       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.